ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2014, Vol. 23 ›› Issue (2): 146-151.

• 论文 • 上一篇    下一篇

雷公藤多苷对早期糖尿病肾病大鼠肾组织单核细胞趋化蛋白1及结缔组织生长因子表达的影响

  

  • 出版日期:2014-04-28 发布日期:2014-04-28

Effects of Triptergium glycosides on the expression of MCP-1 and CTGF in rats with early diabetic nephropathy

  • Online:2014-04-28 Published:2014-04-28

摘要:

摘  要  目的:观察不同剂量雷公藤多苷(TG)对早期糖尿病肾病(DN)大鼠肾脏单核细胞趋化蛋白1(MCP-1)及结缔组织生长因子(CTGF)表达的影响,探讨其保护肾脏的机制。方法:32只SD大鼠随机分正常对照组(NC组)、糖尿病肾病组(DN组)、小剂量TG干预组(TG1组)及双倍剂量TG干预组(TG2组),8周后分别测定大鼠体质量、血糖(BG)、血白蛋白(ALB)、BUN、SCr及24h尿白蛋白定量(UTP);免疫组化法检测肾CTGF、MCP-1及巨噬细胞表面标志抗原ED-1表达,Western blotting及RT-PCR法分别检测CTGF、MCP-1蛋白及核酸表达。 结果:与NC组相比,DN组大鼠BG、ALB、BUN、SCr和UTP显著升高(P<0.05);与DN组相比,TG干预组ALB及UTP均明显好转(P<0.01),其中TG2组更明显;DN组肾组织ED-1阳性细胞数显著高于NC组(P<0.01),而TG1与TG2组较DN组明显减少(P<0.01),其中TG2组较明显。DN组肾脏CTGF、MCP-1蛋白及核酸表达显著增多(P<0.01),TG1及TG2组较DN组表达均明显减少,其中TG2组下降更明显。结论:MCP-1及CTGF可能参与DN发病及进展,TG可能通过下调其表达及减少巨噬细胞浸润起到保护作用,不同剂量TG对DN的干预效果不同,双倍剂量效果更显著。

关键词: 糖尿病肾病, 雷公藤多苷, 结缔组织生长因子, 单核细胞趋化蛋白1,  , 大鼠

Abstract:

ABSTRACT Objective: To investigate the effect of different doses of Triptergium glycosides (TG) on the expression of monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CTGF) in early diabetic nephropathy (DN) rats and to explore its mechanism of renal protection. Methodology: Thirty two SD rats were randomly divided into normal control group (NC, n=8), diabetic nephropathy group (DN, n=8), DN treated with small dose of TG group (TG1, n=8) and double dose TG group (TG2, n=8). After 8 weeks, the rat body weight, blood glucose(BG), albumin (ALB), BUN, SCr and 24 hours urinary total protein(UTP) were tested. The Expression of CTGF, MCP-1 and ED-1 was detected by immunohistochemistry. The gene and protein expression of CTGF and MCP-1 in renal tissue was detected by RT-PCR and western blotting. Results: Compared with NC group, the levels of BG, ALB, SCr, BUN and UTP were significantly increased in DN group (P<0.01). Compared with DN group, the levels of ALB and UTP were better significantly in TG group (P<0.05), particularly in TG2 group. The number of ED-1 positive cells was increased significantly in DN group (P<0.01), while which was inhibited by TG treatment (in TG1 and TG2 group, P<0.01), particularly in TG2 group. The expression of CTGF, MCP-1 and CTGF mRNA, MCP-1 mRNA was significantly increased (P<0.01) in DN group, while which was also inhibited by TG treatment, particularly in TG2 group. Conclusion: MCP-1 and CTGF may be involved in the pathogenesis and progression of DN. TG can ameliorate the renal injury of diabetic rats by decreasing the MCP-1 and CTGF expression and reducing the activation of macrophages. The effects of different doses of TG on DN are different, double dose TG may be effective greater.

Key words: Diabetic nephropathy, Triptergium glycosides, Connective tissue growth factor, Monocyte chemoattractant protein-1,  Rats